Rick Schafer
Stock Analyst at Oppenheimer
(4.85)
# 78
Out of 5,149 analysts
176
Total ratings
68.52%
Success rate
23.04%
Average return
Main Sectors:
Stocks Rated by Rick Schafer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVDA NVIDIA | Reiterates: Outperform | $265 | $180.05 | +47.18% | 27 | Feb 26, 2026 | |
| ADI Analog Devices | Reiterates: Outperform | $350 → $400 | $338.99 | +18.00% | 24 | Feb 19, 2026 | |
| AVGO Broadcom | Maintains: Outperform | $435 → $450 | $313.84 | +43.39% | 22 | Dec 12, 2025 | |
| MRVL Marvell Technology | Reiterates: Outperform | $115 → $150 | $77.51 | +93.52% | 18 | Dec 3, 2025 | |
| SMTC Semtech | Reiterates: Outperform | $81 | $90.17 | -10.17% | 11 | Nov 25, 2025 | |
| MPWR Monolithic Power Systems | Maintains: Outperform | $700 → $800 | $1,074.37 | -25.54% | 21 | Jul 15, 2025 | |
| VECO Veeco Instruments | Reiterates: Outperform | $40 → $35 | $32.47 | +7.79% | 13 | Feb 7, 2025 | |
| NXPI NXP Semiconductors | Maintains: Outperform | $330 → $300 | $215.25 | +39.37% | 11 | Nov 6, 2024 | |
| TXN Texas Instruments | Maintains: Perform | n/a | $202.67 | - | 8 | Apr 24, 2024 | |
| AKTS Aktis Oncology | Maintains: Outperform | $6 → $3 | $20.22 | -85.16% | 5 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $6 | $1.44 | +316.67% | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $81.27 | - | 4 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $120 | $84.11 | +42.67% | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $268 | $46.38 | +477.84% | 1 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $138.38 | - | 8 | Mar 1, 2017 |
NVIDIA
Feb 26, 2026
Reiterates: Outperform
Price Target: $265
Current: $180.05
Upside: +47.18%
Analog Devices
Feb 19, 2026
Reiterates: Outperform
Price Target: $350 → $400
Current: $338.99
Upside: +18.00%
Broadcom
Dec 12, 2025
Maintains: Outperform
Price Target: $435 → $450
Current: $313.84
Upside: +43.39%
Marvell Technology
Dec 3, 2025
Reiterates: Outperform
Price Target: $115 → $150
Current: $77.51
Upside: +93.52%
Semtech
Nov 25, 2025
Reiterates: Outperform
Price Target: $81
Current: $90.17
Upside: -10.17%
Monolithic Power Systems
Jul 15, 2025
Maintains: Outperform
Price Target: $700 → $800
Current: $1,074.37
Upside: -25.54%
Veeco Instruments
Feb 7, 2025
Reiterates: Outperform
Price Target: $40 → $35
Current: $32.47
Upside: +7.79%
NXP Semiconductors
Nov 6, 2024
Maintains: Outperform
Price Target: $330 → $300
Current: $215.25
Upside: +39.37%
Texas Instruments
Apr 24, 2024
Maintains: Perform
Price Target: n/a
Current: $202.67
Upside: -
Aktis Oncology
Sep 7, 2023
Maintains: Outperform
Price Target: $6 → $3
Current: $20.22
Upside: -85.16%
Jun 9, 2023
Maintains: Outperform
Price Target: $7 → $6
Current: $1.44
Upside: +316.67%
Jan 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $81.27
Upside: -
Dec 20, 2021
Maintains: Outperform
Price Target: $175 → $120
Current: $84.11
Upside: +42.67%
Nov 9, 2021
Maintains: Outperform
Price Target: $329 → $268
Current: $46.38
Upside: +477.84%
Mar 1, 2017
Downgrades: Perform
Price Target: n/a
Current: $138.38
Upside: -